Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2016, Article ID 8972570, 7 pages
http://dx.doi.org/10.1155/2016/8972570
Review Article

PPARγ as a Novel Therapeutic Target in Lung Cancer

1Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
2Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA 15240, USA

Received 18 June 2016; Accepted 7 August 2016

Academic Editor: George G. Chen

Copyright © 2016 Aravind T. Reddy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Zhiyuan Tang, Hao Xie, Christoph Heier, Jianfei Huang, Qiuling Zheng, Thomas O. Eichmann, Gabriele Schoiswohl, Pingan Chang, Rudolf Zechner, Songshi Ni, and Haiping Hao, “Enhanced Monoacylglycerol Lipolysis by ABHD6 Promotes NSCLC Pathophysiology,” SSRN Electronic Journal, . View at Publisher · View at Google Scholar
  • Irina Tikhanovich, Jie Zhao, Jody Olson, Abby Adams, Ryan Taylor, Brian Bridges, Laurie Marshall, Benjamin Roberts, and Steven A. Weinman, “Protein arginine methyltransferase 1 modulates innate immune responses through regulation of peroxisome proliferator-activated receptor ?-dependent macrophage differentiation,” Journal of Biological Chemistry, vol. 292, no. 17, pp. 6882–6894, 2017. View at Publisher · View at Google Scholar
  • Roberto Salvi, Cristal Cerqueira-Coutinho, Eduardo Ricci-Junior, Sofia Nascimento dos Santos, Suyene Rocha Pinto, Emerson Soares Bernardes, Patricia Lopes Barros de Araujo, and Ralph Santos-Oliveira, “ Diagnosing lung cancer using etoposide microparticles labeled with 99m Tc ,” Artificial Cells, Nanomedicine, and Biotechnology, pp. 1–5, 2017. View at Publisher · View at Google Scholar
  • Bahar Tunctan, Sefika P. Kucukkavruk, Meryem Temiz-Resitoglu, Demet S. Guden, Ayse N. Sari, and Seyhan Sahan-Firat, “Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock,” Inflammation, 2017. View at Publisher · View at Google Scholar
  • Mengfan Yue, Ni Zeng, Yufeng Xia, Zhifeng Wei, and Yue Dai, “Morin Exerts Anti-Arthritic Effects by Attenuating Synovial Angiogenesis via Activation of Peroxisome Proliferator Activated Receptor-γ,” Molecular Nutrition & Food Research, pp. 1800202, 2018. View at Publisher · View at Google Scholar
  • Sumanta Pal, Catherine Elix, and Jeremy Jones, “The role of peroxisome proliferator-activated receptor gamma in prostate cancer,” Asian Journal of Andrology, vol. 20, no. 3, pp. 238–243, 2018. View at Publisher · View at Google Scholar
  • Junrui Cheng, Benchun Miao, Kang-Quan Hu, Xueyan Fu, and Xiang-Dong Wang, “Apo-10’-lycopenoic acid inhibits cancer cell migration and angiogenesis and induces peroxisome proliferator-activated receptor γ,” The Journal of Nutritional Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Yali Xu, Yejun Qin, Xiaoyan Lin, Jiawen Xu, Yintao Li, and Haiyan Jing, “SULT1E1 inhibits cell proliferation and invasion by activating PPARγ in breast cancer,” Journal of Cancer, vol. 9, no. 6, pp. 1078–1087, 2018. View at Publisher · View at Google Scholar
  • Zhongming Zhao, and Pinyi Lu, “Advances on PPARγ research in the emerging era of precision medicine,” Current Drug Targets, vol. 19, no. 6, pp. 663–673, 2018. View at Publisher · View at Google Scholar